Executive Committee

CTS EVENTIM: Proposed sale of Vivendi’s festival and international ticketing activities to CTS EVENTIM

Retrieved on: 
Wednesday, April 10, 2024
Culture, Growth, Sale, Acquisition, Executive Committee, See Tickets, Music, CTS, Film industry

Paris/Munich, 2 April 2024 – CTS EVENTIM, a leading international provider of ticketing services and live entertainment, and Vivendi, a global leader in culture, entertainment, media and communications, have signed a put option agreement on the sale of Vivendi’s festival and international ticketing activities.

Key Points: 
  • Paris/Munich, 2 April 2024 – CTS EVENTIM, a leading international provider of ticketing services and live entertainment, and Vivendi, a global leader in culture, entertainment, media and communications, have signed a put option agreement on the sale of Vivendi’s festival and international ticketing activities.
  • Vivendi’s ticketing and festival activities that CTS EVENTIM is set to acquire collectively produced €137 million in revenues in 2023.
  • With CTS EVENTIM, Vivendi has found a fitting new home for its festival and international ticketing activities.
  • CTS EVENTIM has been in the festival business for many years, and is committed to continually expanding this vibrant segment.

ABB Ltd: Tarak Mehta to leave ABB

Retrieved on: 
Wednesday, April 10, 2024
Tarak, Automation, Central business district, Software, Engineering, ABB, Executive Committee, Management

ABB announced today that Tarak Mehta, President Motion Business Area and Member of the Executive Committee, has decided to leave ABB since he has accepted the role as CEO of another company.

Key Points: 
  • ABB announced today that Tarak Mehta, President Motion Business Area and Member of the Executive Committee, has decided to leave ABB since he has accepted the role as CEO of another company.
  • Tarak will leave ABB at the end of July this year.
  • Tarak joined ABB in 1998 and has since then held a number of positions of increasing responsibility in the United States, Sweden and Switzerland.
  • I wish the ABB team a continued bright future,” said Tarak Mehta.

ABB Ltd: ABB shareholders approve all proposals at 2024 Annual General Meeting

Retrieved on: 
Wednesday, April 10, 2024
Automation, Annual, Proxy, Executive Committee, Software, Bank statement, Annual general meeting, ABB, CHF, Engineering, Person, Holding company

ABB shareholders have approved all the proposals of the company’s Board of Directors at its 2024 Annual General Meeting, which was held in Zurich, Switzerland, today.

Key Points: 
  • ABB shareholders have approved all the proposals of the company’s Board of Directors at its 2024 Annual General Meeting, which was held in Zurich, Switzerland, today.
  • A total of 623 shareholders attended the meeting who, together with the independent proxy, represented 57.7 percent of the total share capital with a right to vote.
  • The shareholders also approved the management report, the consolidated financial statements and the annual financial statements for 2023.
  • Furthermore, the shareholders granted discharge to the Board of Directors and the persons entrusted with management for the financial year 2023.

Valbiotis to launch its 100% natural dietary supplement for the management of hypercholesterolemia on the French market in May

Retrieved on: 
Wednesday, April 10, 2024
Cholecalciferol, LDL, CRM, Cholesterol, Cardiovascular disease, Medicine, Digital, Dietary supplement, Business, Risk, Patient, Pharmacy, DSM-IV codes, ERP, Research, Stroke, Pharmacist, Business development, Executive Committee, HEART, Artery, Research and development, Omega-3 fatty acid, Safety, Enterocyte, Lipid metabolism, General practitioner, Marketing, Practitioner, Sleep, Hypercholesterolemia, Pharmaceutical industry

The natural and innovative characteristics of this product clearly position Valbiotis®PRO Cholestérol as a leader in the lifestyle and dietary management of hypercholesterolemia, a major risk factor for cardiovascular disease."

Key Points: 
  • The natural and innovative characteristics of this product clearly position Valbiotis®PRO Cholestérol as a leader in the lifestyle and dietary management of hypercholesterolemia, a major risk factor for cardiovascular disease."
  • Available behind the counter in pharmacies, the dietary supplement will also be sold without a prescription with a pharmacist’s recommendation.
  • It comprises a new generation of dietary supplements with active ingredients of natural origin, acting on several targets for comprehensive management.
  • A principal mechanism controls intestinal cholesterol absorption, while a complementary mechanism acts on hepatic metabolism for a comprehensive approach to the management of hypercholesterolemia.

TradeXBank AG appoints Viviane Gabard as new Chief Risk Officer

Retrieved on: 
Wednesday, April 10, 2024
FINMA, Commodity, Risk management, Growth, Central bank, Risk, Metal, Executive Committee, Head, Senior, Fertilizer, Bank, European Central Bank, Management

TradeXBank AG announces that it has appointed Viviane Gabard as new Chief Risk Officer.

Key Points: 
  • TradeXBank AG announces that it has appointed Viviane Gabard as new Chief Risk Officer.
  • Zurich, 25 March 2024 – TradeXBank AG today announced the appointment of Viviane Gabard as Chief Risk Officer following Hendrik Weber-Grellet’s decision to leave the bank.
  • Viviane Gabard is due to become a member of the Executive Board upon the conclusion of the necessary regulatory approval.
  • Camille Sednaoui, TradeXBank AG's CEO, says: “I’m delighted to announce Viviane’s appointment as our new Chief Risk Officer.

PolyPeptide publishes invitation to the annual General Meeting 2024

Retrieved on: 
Wednesday, April 10, 2024
Management, CDMO, Consolidated, Committee, Independent, AGM, Mass meeting, Executive Committee, Proxy, Remuneration

Baar, 19 March 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients,

Key Points: 
  • Baar, 19 March 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients,
    published today the invitation to the third annual General Meeting which will take place on 10 April 2024 at the Chollerhalle in Zug.
  • At PolyPeptide Group AG’s (the “Company”) third annual General Meeting which will take place on 10 April 2024 at the Chollerhalle in Zug (the “AGM 2024”), six current members of the Board of Directors will stand for re-election.
  • Dorothee A. Deuring has decided not to stand for re-election as a member of the Board of Directors.
  • The Board of Directors further proposes to the AGM 2024 the deletion of art.

DKSH’s 91st Annual General Meeting 2024

Retrieved on: 
Wednesday, April 10, 2024
Growth, Nomination, DKSH, Executive Committee, Annual general meeting, Compensation, Proxy, Report, CHF, Holding company

Zurich, Switzerland, March 26, 2024 – DKSH’s shareholders have voted in favor of all motions at the company’s 91st Annual General Meeting by a solid majority.

Key Points: 
  • Zurich, Switzerland, March 26, 2024 – DKSH’s shareholders have voted in favor of all motions at the company’s 91st Annual General Meeting by a solid majority.
  • In total, 175 shareholders were present and a total of 52,929,311 shares, equaling 81.38% of the share capital, were represented at the meeting.
  • Marco Gadola was reelected as Chairman, and all current Board members as well as the members of the Nomination and Compensation committee were reelected for another term of office until completion of the next Annual General Meeting.
  • DKSH will distribute CHF 146.1 million to shareholders, with the payout expected to be made as of April 3, 2024.

Shareholders approved all resolutions

Retrieved on: 
Wednesday, April 10, 2024
Audit, AGM, Executive Committee, HRC, Committee on Finance, CHF, Holding company

Dividend payout of CHF 0.20 per share was approved.

Key Points: 
  • Dividend payout of CHF 0.20 per share was approved.
  • All Board Members who stood for re-election were voted in.
  • Sustainability Report 2023 was approved.
  • Pfäffikon, Schwyz, Switzerland – March 21, 2024 – A total of 215 shareholders attended Oerlikon’s 51st Annual General Meeting of Shareholders (AGM) at the ENTRA, Rapperswil-Jona, Switzerland, and 63.32% of the total share capital was represented.

7th Annual General Meeting: Shareholders approve all proposals

Retrieved on: 
Wednesday, April 10, 2024
Management, Annual, Financial statement, Growth, Galenica, Executive Committee, CHF, Remuneration, Holding company

The seventh Annual General Meeting of Galenica Ltd. was held on 10 April 2024 at the Kursaal in Bern.

Key Points: 
  • The seventh Annual General Meeting of Galenica Ltd. was held on 10 April 2024 at the Kursaal in Bern.
  • The shareholders approved all the proposals put forward by the Board of Directors.
  • The Annual General Meeting also approved the dividend at the prior-year level of CHF 2.20 per share proposed by the Board of Directors.
  • The dividend for the 2023 financial year will be paid to shareholders from 16 April 2024.

49th Annual General Meeting of BELIMO Holding AG Approves All Motions

Retrieved on: 
Wednesday, April 10, 2024
Committee, Heat, Independent, BELIMO Holding AG, Ventilation, SIX Swiss Exchange, Executive Committee, Annual general meeting, CHF, Remuneration, External auditor, Holding company

The 49th Annual General Meeting of BELIMO Holding AG was held on March 25, 2024.

Key Points: 
  • The 49th Annual General Meeting of BELIMO Holding AG was held on March 25, 2024.
  • The shareholders approved the proposed amendments to the Articles of Incorporation of BELIMO Holding AG, which are mainly in response to revisions to the Swiss company law.
  • Taking these amendments into account, the proposed maximum remuneration of the Board of Directors from January 1, 2024, to the 2024 Annual General Meeting, and from the 2024 Annual General Meeting to the 2025 Annual General Meeting, were approved.
  • The shares of BELIMO Holding AG have been traded on the SIX Swiss Exchange since 1995 (BEAN).